These results indicated that low-dose dexamethasone has anti-tumor activity by suppressing PD-L1 and IDO1, but high-dose dexamethasone induced tumor growth by suppressing tumor immune surveillance, which indicates dexamethasone as a double-edged sword [41]. The gene discussed is IDO1; the disease is neoplasm.